Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TRC 150094

Drug Profile

TRC 150094

Alternative Names: T2-mimetic; TRC150094

Latest Information Update: 22 Nov 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Torrent Pharmaceuticals
  • Class Antihyperglycaemics; Antihypertensives; Indenes; Obesity therapies; Peptidomimetics; Propionic acids; Pyrazoles
  • Mechanism of Action Thyroid hormone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Diabetes mellitus; Dyslipidaemias; Hypertension
  • No development reported Metabolic syndrome

Most Recent Events

  • 22 Nov 2019 Chemical structure information added
  • 26 Aug 2019 Torrent Pharmaceuticals discontinues a phase III trial in Diabetes mellitus, Dyslipidaemias and Hypertension (Adjunctive treatment) in Sri Lanka (PO) (SLCTR2018-009)
  • 24 Jun 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top